Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 77

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 77
---
 follows (in thousands, except weighted average remaining lease term and weighted average discount rate):June 30,2025December 31,2024Finance LeasesProperty and equipment, at cost$1,031 $1,031 Less: accumulated depreciation and amortization(1,025)(1,023)Property and equipment, net$6 $8 Operating LeasesOperating lease right-of-use assets$1,496 $657 Total operating lease right-of-use assets$1,496 $657 Current portion of operating lease liabilities$525 $420 Operating lease liabilities, less current portion1,059 372 Total operating lease liabilities$1,584 $792 Weighted Average Remaining Lease TermOperating leases (in years)33Weighted Average Discount RateOperating leases12.6%9.9%Maturities of lease liabilities were as follows (in thousands):Year Ended December 31,OperatingLeases2025 (excluding the six months ended June 30, 2025)$416 2026555 2027545 2028366 202940 Thereafter— Total lease payments1,922 Less: future interest expense(338)Lease liabilities$1,584 

L.    Goodwill & Intangible AssetsThe Company's goodwill balance was $4.7 million as of June 30, 2025, and December 31, 2024. As of June 30, 2025, and December 31, 2024, non-amortizable intangible assets include $2.0 million related to in-process research and development associated with the Merger.

26

The definite-lived intangible assets that are subject to amortization have been reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. In the second quarter of 2025, the Company assessed the results of its refined commercial efforts related to OLPRUVA. This was determined to be a triggering event that could result in a decrease in future expected cash flows, and thus indicated the carrying amount of the OLPRUVA asset group may not be fully recoverable. The Company performed an undiscounted cash flow analysis over the OLPRUVA asset group and determined that the carrying value of the asset group is not recoverable. Future cash flows specific to OLPRUVA, which most significantly includes an estimate of forecasted revenues, are based on reasonable and supportable assumptions regarding the cash flows expected to result from